{"address1": "18702 N. Creek Parkway", "address2": "Suite 100", "city": "Bothell", "state": "WA", "zip": "98011", "country": "United States", "phone": "425 939 7410", "website": "https://immunome.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises of AL102, a gamma secretase inhibitor which is in phase 3 clinical trial for the treatment of desmoid tumors; IM-1021, a receptor tyrosine kinase-like orphan receptor 1 and antibody-drug conjugates which is in phase 1 clinical trial; and preclinical asset consist of IM-3050, a fibroblast activation protein targeted radioligand therapy. It also develops solid tumor ADC drug candidates which includes IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.", "fullTimeEmployees": 118, "companyOfficers": [{"maxAge": 1, "name": "Dr. Clay B. Siegall Ph.D.", "age": 63, "title": "Chairman, President & CEO", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 1433088, "exercisedValue": 0, "unexercisedValue": 12996163}, {"maxAge": 1, "name": "Dr. Jack  Higgins Ph.D.", "age": 44, "title": "Chief Scientific Officer", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 956342, "exercisedValue": 0, "unexercisedValue": 734891}, {"maxAge": 1, "name": "Dr. Robert J. Lechleider M.D.", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 512488, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Max  Rosett", "age": 34, "title": "Chief Financial Officer", "yearBorn": 1990, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philip  Tsai", "title": "Chief Technical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sandra G. Stoneman Esq., J.D.", "age": 50, "title": "Chief Legal Officer, General Counsel & Corporate Secretary", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 443432, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kinney  Horn", "age": 49, "title": "Chief Business Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Roee  Shahar", "title": "Executive Vice President of Commercial", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 10, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.73, "open": 6.65, "dayLow": 6.19, "dayHigh": 6.89, "regularMarketPreviousClose": 6.73, "regularMarketOpen": 6.65, "regularMarketDayLow": 6.19, "regularMarketDayHigh": 6.89, "payoutRatio": 0.0, "beta": 1.94, "forwardPE": -2.1586206, "volume": 1195430, "regularMarketVolume": 1195430, "averageVolume": 1077138, "averageVolume10days": 1997910, "averageDailyVolume10Day": 1997910, "bid": 6.09, "ask": 6.41, "bidSize": 11, "askSize": 11, "marketCap": 544311424, "fiftyTwoWeekLow": 6.19, "fiftyTwoWeekHigh": 22.025, "priceToSalesTrailing12Months": 60.20478, "fiftyDayAverage": 9.3502, "twoHundredDayAverage": 12.033275, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 331840096, "profitMargins": 0.0, "floatShares": 69554437, "sharesOutstanding": 86950704, "sharesShort": 9523078, "sharesShortPriorMonth": 9350699, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.1095, "heldPercentInsiders": 0.16225, "heldPercentInstitutions": 0.57648, "shortRatio": 13.83, "shortPercentOfFloat": 0.113800004, "impliedSharesOutstanding": 90511600, "bookValue": 2.81, "priceToBook": 2.2277582, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -292963008, "trailingEps": -5.0, "forwardEps": -2.9, "enterpriseToRevenue": 36.704, "enterpriseToEbitda": -2.185, "52WeekChange": -0.71018517, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 6.26, "targetHighPrice": 38.0, "targetLowPrice": 20.0, "targetMeanPrice": 27.14286, "targetMedianPrice": 25.0, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 217303008, "totalCashPerShare": 2.499, "ebitda": -151888992, "totalDebt": 4832000, "quickRatio": 4.001, "currentRatio": 4.076, "totalRevenue": 9041000, "debtToEquity": 2.667, "revenuePerShare": 0.154, "returnOnAssets": -0.49339, "returnOnEquity": -1.94629, "grossProfits": -120501000, "freeCashflow": -96318000, "operatingCashflow": -110794000, "revenueGrowth": -0.284, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -20.306059, "financialCurrency": "USD", "symbol": "IMNM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NCM", "messageBoardId": "finmb_108518404", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "preMarketTime": 1743595750, "regularMarketTime": 1743537602, "regularMarketChangePercent": -6.983652, "regularMarketPrice": 6.26, "shortName": "Immunome, Inc.", "longName": "Immunome, Inc.", "marketState": "PRE", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1601645400000, "preMarketChange": 0.119999886, "preMarketChangePercent": 1.916931, "preMarketPrice": 6.38, "regularMarketChange": -0.4699998, "regularMarketDayRange": "6.19 - 6.89", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1077138, "fiftyTwoWeekLowChange": 0.07000017, "fiftyTwoWeekLowChangePercent": 0.01130859, "fiftyTwoWeekRange": "6.19 - 22.025", "fiftyTwoWeekHighChange": -15.764999, "fiftyTwoWeekHighChangePercent": -0.7157775, "fiftyTwoWeekChangePercent": -71.01852, "earningsTimestamp": 1742414700, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -5.0, "epsForward": -2.9, "epsCurrentYear": -2.41, "priceEpsCurrentYear": -2.5975103, "fiftyDayAverageChange": -3.0901995, "fiftyDayAverageChangePercent": -0.33049557, "twoHundredDayAverageChange": -5.7732744, "twoHundredDayAverageChangePercent": -0.47977585, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-10-02", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "displayName": "Immunome", "trailingPegRatio": null}